Search clinical trials for: Solid tumours,

Total 9037 results

Chinese University of Hong Kong
Agilis Robotics Limited

Not yet recruiting

First-in-Human Trial of a Novel Endoluminal Robotic System for En-Bloc Resection of Bladder Tumours

Bladder Cancer
Royal Marsden NHS Foundation Trust
Institute of Cancer Research, United Kingdom; Onyx Therapeutics, Inc.

Completed

Phase I Trial of ONX-0801 Once Weekly or Alternate Weekly (ONX-0801)

Solid Tumours

United Kingdom
Debiopharm International SA

Terminated

Debio 1347-101 Phase I Trial in Advanced Solid Tumours With Fibroblast Growth Factor Receptor (FGFR) Alterations

Solid Tumours

Korea, Republic of, United States, Taiwan, Spain, Singapore
AstraZeneca

Completed

To Assess the Effect of Itraconazole and Fluconazole on the Pharmacokinetics of Selumetinib in Healthy Male Volunteers

Solid Tumours

United States
AstraZeneca

Completed

To Assess the Effect of Food on the Pharmacokinetics of Selumetinib (AZD6244; ARRY-142886) (Hyd-Sulfate) in Healthy Male Volunteers

Solid Tumours

United States
AstraZeneca
Parexel

Completed

A Study in Healthy Male Subjects to Understand How Savolitinib Behaves Inside the Body (Pharmacokinetics) When Administered Alone and in Combination With Famotidine

Solid Tumours

United States
AstraZeneca
Quintiles, Inc.

Completed

Effects of AZD1775 on the PK Substrates for CYP3A, CYP2C19, CYP1A2 and on QT Interval in Patients With Advanced Cancer

Solid Tumours

United States
SOLTI Breast Cancer Research Group
Novartis; Roche Pharma AG; Guardant Health, Inc.

Active, not recruiting

Real World Study Using Comprehensive Genomic Data on the Next Treatment Decision Making in Metastatic Breast Cancer (HOPE)

Metastatic Breast Cancer

Spain
AstraZeneca

Recruiting

Investigating Safety, Tolerability, Efficacy and PK of Olaparib in Paediatric Patients With Solid Tumours

Solid Tumours

Australia, Korea, Republic of, Germany, United States, Spain, France, Canada, Italy, Austria, Israel, United Kingdom, Denmark, Hungary, Poland, Russian Federation, Ukraine, Brazil
Modra Pharmaceuticals

Completed

Extended Use of ModraDoc006/r

Advanced Solid Tumours

Netherlands
AstraZeneca

Completed

Study to Assess the Blood Levels and Safety of AZD9291 in Patients With Advanced Solid Tumours and Normal Liver Function or Mild or Moderate Liver Impairment

Solid Tumours

United States, Spain, Belgium, France, Korea, Republic of, United Kingdom
AstraZeneca

Completed

D081AC00001 Food Interaction With Olaparib Capsule in Patients With Solid Tumours

Solid Tumours

Belgium, United Kingdom, Netherlands
GlaxoSmithKline

Completed

A Dose Escalation Study of the Safety and Pharmacokinetics of GSK1363089 (Formerly XL880) Administered Orally Daily to Subjects With Solid Tumors

Solid Tumours
Welichem Biotech Inc.
Ozmosis Research Inc.

Completed

Safety Study of SLC-0111 in Subjects With Advanced Solid Tumours

Solid Tumours

Canada
LondonPharma Ltd.

Unknown

A Phase 1/2a Study of LON002 in Subjects With Advanced Solid Tumours (LON002-002)

Solid Tumours

United Kingdom
Hoffmann-La Roche

Recruiting

A Worldwide Cancer Registry Enrolling Participants Profiled With a Next-Generation Sequencing Test

Solid Tumours

Brazil, Germany, Taiwan, United Kingdom, France, Turkey, Slovenia, Canada, Ireland, India, Portugal, Thailand, South Africa, Serbia, Israel, Colombia, Spain, Greece, Mexico, Poland, Philippines, Argentina, Egypt, Chile, Estonia, Lebanon, Sl... and more
AstraZeneca

Completed

To Assess Safety and Effect of Olaparib on the Pharmacokinetics of Anastrozole, Letrozole & Tamoxifen, and Their Effect on Olaparib, in Patients With Advanced Solid Cancer

Solid Tumours

Belgium, Denmark, France, United Kingdom, Netherlands
AstraZeneca

Completed

To Assess the Effects of Single Oral Dose of Selumetinib [AZD6244; ARRY-142886] [Hyd-Sulfate]), on QTc Interval in Healthy Male Volunteers

Solid Tumours

United States
AstraZeneca

Completed

Study Evaluating Absorption, Distribution, Metabolism and Excretion (ADME) of Single Dose [14C] Selumetinib in Volunteers

Solid Tumours

United Kingdom
LondonPharma Ltd.

Unknown

An Extension Study of LON002 in Patients With Cancer

Solid Tumours

United Kingdom
AstraZeneca

Completed

To Assess the Effect of Rifampicin on the Pharmacokinetics of Selumetinib in Healthy Male Volunteers

Solid Tumours

United States
Zhuhai Beihai Biotech Co., Ltd

Completed

Phase I Clinical Trial of BH002 in Patients With Advanced Solid Tumors (BH002-Ⅰ-101)

Solid Tumours

China
AstraZeneca
Syneos Health

Completed

Study to Assess the Safety and Preliminary Efficacy of AZD0156 at Increasing Doses Alone or in Combination With Other Anti-cancer Treatment in Patients With Advanced Cancer (AToM)

Advanced Solid Tumours

United States, Spain, Korea, Republic of, United Kingdom
Orion Corporation, Orion Pharma

Completed

Safety and Tolerability of ODM-203 in Subjects With Advanced Solid Tumours (KIDES-203)

Solid Tumours

France, Finland, Spain, Italy, Denmark, United Kingdom
GlaxoSmithKline

Completed

Open-label Study of Topotecan and Pazopanib in Advanced Solid Tumors

Solid Tumours

United States, Netherlands
GlaxoSmithKline

Completed

A Dose Escalation Study of the Safety and Pharmacokinetics of GSK1363089 (Formerly XL880) Administered Orally to Subjects With Solid Tumors

Solid Tumours
GlaxoSmithKline

Completed

A Bioavailability Study of GSK1363089 in Subjects With Solid Tumors

Solid Tumours

United States
EDDC (Experimental Drug Development Centre), A*STAR...
Parexel

Recruiting

A Study of EBC-129 in Advanced Solid Tumours

Advanced Solid Tumours

United States, Singapore
RemeGen Co., Ltd.

Recruiting

A Study to Assess the Safety and Tolerability of RC88 for Patients With Advanced Solid Tumours

Advanced Solid Tumours

China
Suzhou Suncadia Biopharmaceuticals Co., Ltd.

Not yet recruiting

A Study of SHR-A1921 for Injection in Subjects With Advanced Solid Tumours

Advanced Solid Tumours
AstraZeneca

Active, not recruiting

A Study to Evaluate the Safety and Pharmacokinetics of Ceralasertib in Combination With Durvalumab in Chinese Patients With Advanced Solid Tumours

Advanced Solid Tumours

China
Exscientia AI Limited
Biotrial

Terminated

Study to Assess EXS21546 in Combination in Patients With Advanced Solid Tumours

Advanced Solid Tumours

France, Belgium
Centre Hospitalier Universitaire de Saint Etienne

Completed

Comparison of Dermatoscopy X400 Interpreted by 6 Non-dermatologists and an Artificial Intelligence Software Skin Artificial Intelligence Versus Dermatoscopy x 20

Pigmented Lesions | Genital Tumor

France
Chinese PLA General Hospital

Recruiting

Allogeneic γδ T Cell Therapy for the Treatment of Solid Tumors

Malignant Solid Tumours

China
AstraZeneca
Parexel

Terminated

A Study to Assess the Safety and Tolerability of Adavosertib for Patients With Advanced Solid Tumours

Advanced Solid Tumours

United Kingdom, United States
Iqvia Pty Ltd

Terminated

Phase I Trial of bacTRL-IL-12 in Adult Subjects With Advanced, Treatment-refractory Solid Tumours

Cancer - Solid Tumours

Australia
Cancer Research UK

Terminated

A Phase I Study of AZD0424 Alone and in Combination in Advanced Solid Tumours (AZD0424)

Advanced Solid Tumours

United Kingdom
University Health Network, Toronto
Princess Margaret Hospital, Canada

Completed

Pantoprazole With Doxorubicin for Advanced Cancer Patients With Extension Cohort of Patients With Solid Tumours

Advanced Solid Tumours

Canada
Prodimed S.A.

Completed

PDM08 Clinical Trial in Advanced Solid Tumors

Malignant Solid Tumours

Spain
RemeGen Co., Ltd.

Recruiting

A Study of RC88 Combined With Sintilimab for Advanced Solid Tumours

Advanced Solid Tumours

China
Queen Mary University of London

Recruiting

Tissue Collection Framework To Improve Outcomes In Solid Tumours

Solid Tumours

United Kingdom
AstraZeneca

Completed

To Determine the Effect of Food on the Pharmacokinetics of Olaparib and the Effect of Olaparib on QT Interval Following Oral Dosing of a Tablet Formulation in Patients With Advanced Solid Tumours

Solid Tumours

Denmark, Belgium, United Kingdom, Netherlands
AstraZeneca
Parexel

Terminated

A Study to Assess the Effects of Itraconazole, Rifampicin, and Omeprazole on Pharmacokinetics of Adavosertib

Advanced Solid Tumours

United States, Spain
AstraZeneca

Completed

Capivasertib China PK Study

Advanced Solid Tumours

China
AstraZeneca

Completed

Study to Assess the Blood Levels and Safety of Olaparib in Patients With Advanced Solid Tumours and Normal Liver Function or Mild or Moderate Liver Impairment

Solid Tumours

France, United Kingdom, Czechia, Korea, Republic of, Netherlands
The Third Affiliated Hospital of Guangzhou Medical...

Unknown

Pilot Study of NKG2D-Ligand Targeted CAR-NK Cells in Patients With Metastatic Solid Tumours

Solid Tumours

China
Cancer Research UK

Completed

Phase I Study of AT13148, a Novel AGC Kinase Inhibitor

Advanced Solid Tumours

United Kingdom
AstraZeneca
Quintiles, Inc.

Completed

Phase I Study to Assess the Effect of Food on AZD1775 Pharmacokinetics in Patients With Advanced Solid Tumours

Solid Tumours

France, United Kingdom, Netherlands
GlaxoSmithKline

Completed

Ispinesib In Combination With Carboplatin In Patients With Solid Tumors

Solid Tumours

United States, United Kingdom
AstraZeneca

Completed

Study to Assess the Effect of Rifampicin (CYP Inducer) on Blood Levels and Safety of Olaparib in Patients With Advanced Solid Tumours

Solid Tumours

Netherlands, Belgium

3

Subscribe